U.S. healthcare industry news covers hospital systems, pharmaceutical companies, insurers, medical device makers and health-tech firms as businesses operating within the national system. This section covers the U.S. healthcare industry as a business — hospital system mergers and finances, pharmaceutical earnings and pipeline decisions, insurer rate filings, medical device recalls and approvals and the health-tech investment and IPO activity that reflects how capital views the sector. Coverage spans the institutions and the economics that connect them.
The managed care company reported $0.58 adjusted diluted EPS and said its Medicare Advantage business reached breakeven a year early.
Live Poll
Do you trust health insurance companies to put patients ahead of profits?
November 8, 2026
Elutia Plans FDA Filing for Antibiotic-Coated MatrixElutia's NXT-41x matrix passed a rabbit study and is slated for an FDA filing in the fourth quarter of 2026.
November 8, 2026
Hospitals Lose Money on Complex Knee RevisionsA study of 2,265 revision total knee replacements found hospitals are losing money on complex cases performed in the hospital setting.
November 8, 2026
Ahold Delhaize Agrees to Pay $40 Million SettlementThe multistate settlement resolves False Claims Act allegations over inflated prescription drug prices reported to federal health programs.
November 8, 2026
Sonida Plans $250M in 2026 AcquisitionsThe senior living operator says it expects to deploy about $250 million in acquisition capital this year following its merger with CNL Healthcare Properties.
November 8, 2026
Accendra Health Cuts 2026 Earnings OutlookThe healthcare company now expects adjusted EBITDA as much as 30% below its prior midpoint while it reorganizes commercial operations.
November 8, 2026
Elafibranor, Seladelpar Show Similar Liver OutcomesA propensity-matched study of adults with primary biliary cholangitis found no significant 1-year differences between the two second-line treatments.
November 7, 2026
iRhythm Raises 2026 Revenue OutlookThe medical device maker lifted its full-year revenue range while delaying its Zio MCT regulatory filing to 2027.
November 7, 2026
Artivion Narrows 2026 Revenue OutlookThe medical device maker raised the low end of its revenue range while lowering the high end, as third-quarter revenue grew 9%.
November 7, 2026
TransMedics Sets 2026 Revenue Guidance at $764M-$774MThe forecast includes about $14 million from the recently acquired PAD Aviation business, while comparable guidance excluding it rises to $750 million-$760 million.
November 7, 2026
Insurance Type, Race Linked to Liver Care GapsFour studies presented at The Liver Meeting 2026 in Denver connect insurance coverage and race to disparities in liver disease care.
Coverage takes in hospital merger reviews and rural closure announcements, drug company earnings and pipeline disclosures, insurer rate filings and their regulatory approval, medical device safety proceedings, health-tech funding rounds and the federal reimbursement decisions — through Medicare and Medicaid — that set the economic conditions for the entire sector. Drug pricing has become one of the most sustained subjects in U.S. healthcare business coverage, with legislative negotiations, regulatory actions and legal proceedings running simultaneously and producing stories that span pharmacy, insurance, federal budget and patient access reporting. Rural hospital closures have generated sustained accountability coverage that documents the gap between healthcare access in metropolitan and non-metropolitan markets, with financial data, staffing levels and service reductions each providing measurable indicators of system stress. Pharmacy benefit manager practices — the opaque intermediary role between drug makers, insurers and patients — have attracted congressional and regulatory attention that now generates its own coverage track, separate from the earnings cycle of any individual company.
